NCT04186520
- Conditions
- Central Nervous System Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia (CLL), +28 more
- Locations
-
- Medical College of Wisconsin and Froedtert Hospital Milwaukee, Wisconsin, United States
Clinical trial condition
Diffuse Large B Cell Lymphoma
Explore clinical trials studying Diffuse Large B Cell Lymphoma. Study availability and eligibility vary by location and protocol.
165 public trials
52 recruiting studies
Diffuse Large B Cell Lymphoma trial results
Recruiting
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
NCT05990465
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Diffuse Large B Cell Lymphoma, +23 more
- Locations
-
- Froedtert & the Medical College of Wisconsin Milwaukee, Wisconsin, United States
Recruiting
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
NCT04775745
- Conditions
- Blood Protein Disorders, CLL/SLL, Cardiovascular Diseases, +28 more
- Locations
-
- Duke Univerisity Durham, North Carolina, United States
- University of Cincinnati Cincinnati, Ohio, United States
- Ohio State University Columbus, Ohio, United States
- Huntsman Cancer Institute, University of Utah Salt Lake City, Utah, United States
NCT06517511
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Sun yat-sen university cancer center Guangzhou, Guangdong, China
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
NCT06829771
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
- Maanshan People's Hospital Ma’anshan, Anhui, China
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
- Fujian Cancer Hospital Fuzhou, Fujian, China
NCT07368270
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Suzhou Hongci Hematology Hospital Suzhou, China
NCT06693830
- Conditions
- Diffuse Large B Cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Hemic and Lymphatic Diseases, +15 more
- Locations
-
- Columbia University New York, United States
NCT06588205
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, +11 more
- Locations
-
- A.O.U. SS. Antonio e Biagio e C. Arrigo - S.C.D.U. Ematologia Alessandria, Italy
- A.O.U. Ospedali Riuniti delle Marche - Clinica di Ematologia Ancona, Italy
- I.R.C.C.S. Istituto Tumori Giovanni Paolo II - U.O.C. Ematologia Bari, Italy
- ASST Spedali Civili - S.C. Ematologia Brescia, Italy
NCT06022029
- Conditions
- Bites and Stings, Bladder Cancer, Breast Diseases, +72 more
- Locations
-
- California Research Institute Los Angeles, California, United States
- BRCR Global Tamarac, Florida, United States
- Gabrail Cancer Center Research Canton, Ohio, United States
- Ohio State University Columbus, Ohio, United States
NCT06736613
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B Cell Lymphoma, +21 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States